Global perspective. Clear attribution. Updated throughout the day.
Live desk Concise briefs from trusted publishers · Always follow the source for the full report
Markets
GBP/USD 1.3254 FrankfurterEUR/USD 1.1398 FrankfurterUSD/NGN 1,327.68 FrankfurterUSD/JPY 158.23 FrankfurterGold $4,286.20/oz Gold APISilver $64.42/oz Gold API
Breaking
Trump predicts fresh Iran talks despite rejecting truce proposal Punch NigeriaFederal government approves upgrades for four regional ports Punch NigeriaSoludo urges Anambra residents to help tackle flooding and erosion Punch NigeriaBorno CAN calls for rescue of 78 schoolchildren held captive Punch NigeriaMeerdink double gives Xavi first win as Netherlands coach Punch NigeriaNigeria seeks industrial partnerships as 14 German firms assess investment opportunities Punch NigeriaFlamingos win WAFU-U17 Girls’ Cup after four-goal victory over Togo Punch NigeriaNigeria plans QR certification system for Halal exports Punch NigeriaNigeria reviews health spending as medical bills remain high Punch NigeriaNatarajan case raises questions over electoral disclosure rules The Hindu
Scores
Monterey Bay FC v Lexington SC 2–3 American USL Championship · TheSportsDBNew Mexico United v Sacramento Republic 2–3 American USL Championship · TheSportsDBOakland Roots v Phoenix Rising 3–0 American USL Championship · TheSportsDB
Climate

Pollution board tells tribunal Sun Pharma has not begun proposed Chengalpattu expansion

Source: The Hindu · 27 Sep 2026, 17:30 UTC
Pollution board tells tribunal Sun Pharma has not begun proposed Chengalpattu expansion
Image: The Hindu · original report

The Tamil Nadu Pollution Control Board has told the National Green Tribunal that Sun Pharmaceutical Industries’ Chengalpattu unit is operating within its existing permitted capacity and has not carried out a proposed expansion. The company has environmental clearance for higher production but lacks specific board consent to undertake that expansion, TNPCB said.

The Tamil Nadu Pollution Control Board has told the National Green Tribunal that Sun Pharmaceutical Industries Ltd.’s unit at Sathammai village in Chengalpattu district is operating within its existing permitted capacity and has not undertaken a proposed expansion. The submission was made in a report filed before the southern bench of the NGT in response to an appeal by K.R. Selvaraj Kumar of Meenavar Nala Sangam.

The appeal challenges environmental clearance granted to the company for the expansion. According to the TNPCB, the unit originally received consent to establish in 2005 and consent to operate in 2006 for pharmaceutical production of 25.5 tonnes a month. Later consent orders changed arrangements for sewage, trade effluent and air-pollution control, but did not increase the permitted product quantity.

The company obtained environmental clearance from the Union Ministry of Environment, Forest and Climate Change on March 31, 2022. That clearance covered an increase in active pharmaceutical ingredient production from 25.5 tonnes to 134.082 tonnes a month within the existing plant. However, the board said Sun Pharma had not obtained its consent to establish or consent to operate for carrying out the expansion.

A TNPCB inspection on September 12, 2026, found the unit operating within the existing 25.5-tonne monthly limit, and recorded that no expansion activity had taken place. The dispute also concerns an earlier NGT case filed in 2020. The Tribunal had noted violations connected with operation without environmental clearance for an earlier expansion and confirmed environmental compensation of ₹58.20 lakh for groundwater and soil contamination.

It also directed payment of interim compensation of ₹10 crore and asked the TNPCB to assess any additional amount for operation beyond the permitted pollution load. The board said the company later obtained the 2022 environmental clearance and renewed consent valid until March 31, 2028, but not consent specifically for the expansion.

About this report
This independently written report is based on information supplied by the named publisher. Vertrix News has not independently verified the source report.
View the original source at The Hindu →